Table 4. Plasma chemistry and potassium and magnesium replacement in the patients.

Patients	Mutated genes	Number of mutated SLC12A3	Number of mutated CLCNKB	[K+]	[Mg2+]	K+ replacement (mM/d)	Mg2+ replacement (mM/d)	Potassium-sparing diuretics (mg/d)
1	SLC12A3	2	0	3.5	0.83	24	0	0
2	SLC12A3	2	0	4.3	0.71	48	0	0
3	SLC12A3	2	0	4.1	0.75	64	0	0
4	SLC12A3	2	0	4.5	0.67	120	59	Spironolactone 50
5	SLC12A3	2	0	3.5	0.63	120	235	Spironolactone 25
6	SLC12A3	2	0	3.3	0.88	96	39	Spironolactone 50
7	SLC12A3	2	0	5.0	0.88	168	0	0
8	SLC12A3	2	0	3.2	0.54	48	0	Spironolactone 50
9	SLC12A3	2	0	4.6	0.71	72	39	0
10	SLC12A3	2	0	3.7	0.71	240	59	Spironolactone 50
11	SLC12A3	2	0	3.6	0.50	200	59	Spironolactone 50
12	SLC12A3	2	0	4.0	0.54	96	118	0
13	SLC12A3	2	0	4.2	0.54	96	59	0
14	SLC12A3	2	0	3.2	0.63	128	118	Spironolactone 25
15	SLC12A3	2	0	3.1	0.58	96	88	Spironolactone 25
16	SLC12A3	2	0	4.2	0.79	48	0	Spironolactone 50
17	SLC12A3	2	0	2.9	0.54	160	0	Spironolactone 25
18	SLC12A3	2	0	3.1	0.46	360	352	Spironolactone 50
19	SLC12A3	2	0	3.5	0.63	48	176	Spironolactone 25
20	SLC12A3	2	0	3.0	0.63	128	0	Spironolactone 25
21	SLC12A3	2	0	3.4	0.63	120	0	Spironolactone 50
22	SLC12A3	2	0	3.6	0.46	112	392	0
23	SLC12A3	2	0	3.3	0.58	72	118	0
24	SLC12A3	1	0	3.5	0.67	120	118	Spironolactone 50
25	SLC12A3	1	0	3.4	0.67	160	20	Spironolactone 50
26	SLC12A3	1	0	3.5	0.71	48	39	0
27	SLC12A3	1	0	3.7	0.83	72	0	Spironolactone 50
28	SLC12A3	1	0	2.8	1.08	180	0	0
29	SLC12A3	1	0	3.3	0.71	0	0	0
30	SLC12A3 + CLCNKB	1	1	3.1	0.58	480	881	Amiloride 20
31	SLC12A3 + CLCNKB	1	2	3.8	0.79	272	0	Spironolactone 50
32	CLCNKB	0	2	4.3	0.79	160	0	Amiloride 5
33	CLCNKB	0	2	4.0	0.92	120	0	0
34	CLCNKB	0	1	3.9	0.71	72	0	0

[K⁺], serum potassium concentration (mM/L); [Mg²⁺], serum magnesium concentration (mM/L).